Premium
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2‐year real‐life study
Author(s) -
Di Bona Danilo,
Nettis Eustachio,
Minenna Elena,
Lovecchio Antonella,
Paolino Donato,
Cristiizi Maria,
Albanesi Marcello,
Ridolo Erminia,
Filomena Caiaffa Maria,
Macchia Luigi
Publication year - 2020
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14341
Subject(s) - discontinuation , omalizumab , content (measure theory) , medicine , immunology , surgery , immunoglobulin e , mathematics , antibody , mathematical analysis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom